Literature DB >> 12470174

Hospital and surgeon determinants of carotid endarterectomy outcomes.

Thomas E Feasby1, Hude Quan, William A Ghali.   

Abstract

BACKGROUND: Prior studies have found associations between surgeon and hospital case volumes and outcomes after carotid endarterectomy (CEA), but they have not simultaneously assessed the importance of a number of surgeon and hospital characteristics.
OBJECTIVE: To simultaneously assess associations between hospital case volume, teaching status, clinical trial participation, and surgeon specialty and case volume and the outcome after CEA.
DESIGN: Analysis of a large administrative data-base using logistic regression to correlate adverse outcomes after CEA with surgeon and hospital characteristics. SETTING AND PATIENTS: A Canadian administrative hospital discharge database of all patients undergoing CEA in fiscal years 1994 through 1997. MAIN OUTCOME MEASURES: In-hospital stroke and/or death.
RESULTS: We found an inverse relationship between both hospital and surgeon case volumes and adverse outcomes. Teaching status had no association with outcome, but previous clinical trial participation predicted a better outcome. General surgeons fared worse than other specialists. Low-volume surgeons in low-volume hospitals had a relative risk of 3.5 for adverse outcomes compared with high-volume surgeons in high-volume hospitals.
CONCLUSIONS: Several physician and hospital characteristics are determinants of outcome after CEA, but the negative effects of low hospital and surgeon case volumes, in particular, suggest that regionalization should be considered for CEA and that surgeons with low case volumes should not be performing CEA.

Entities:  

Mesh:

Year:  2002        PMID: 12470174     DOI: 10.1001/archneur.59.12.1877

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  8 in total

1.  The inappropriate use of carotid endarterectomy.

Authors:  Henry J M Barnett
Journal:  CMAJ       Date:  2004-08-31       Impact factor: 8.262

2.  Complication rates and center enrollment volume in the carotid revascularization endarterectomy versus stenting trial.

Authors:  Nicole R Gonzales; Bart M Demaerschalk; Jenifer H Voeks; MeeLee Tom; George Howard; Alice J Sheffet; Lawrence Garcia; Daniel G Clair; John Barr; Steven Orlow; Thomas G Brott
Journal:  Stroke       Date:  2014-09-25       Impact factor: 7.914

Review 3.  Evaluation and Management of Atherosclerotic Carotid Stenosis.

Authors:  James F Meschia; James P Klaas; Robert D Brown; Thomas G Brott
Journal:  Mayo Clin Proc       Date:  2017-07       Impact factor: 7.616

4.  Procedural complications, rehospitalizations, and repeat procedures after catheter ablation for atrial fibrillation.

Authors:  Rashmee U Shah; James V Freeman; David Shilane; Paul J Wang; Alan S Go; Mark A Hlatky
Journal:  J Am Coll Cardiol       Date:  2012-01-10       Impact factor: 24.094

5.  Association of physician certification and outcomes among patients receiving an implantable cardioverter-defibrillator.

Authors:  Jeptha P Curtis; Jeffrey J Luebbert; Yongfei Wang; Saif S Rathore; Jersey Chen; Paul A Heidenreich; Stephen C Hammill; Rachel I Lampert; Harlan M Krumholz
Journal:  JAMA       Date:  2009-04-22       Impact factor: 56.272

6.  Carotid stenosis: endarterectomy or angioplasty and stenting?

Authors:  Jeffrey A Switzer; David C Hess
Journal:  Curr Treat Options Neurol       Date:  2007-11       Impact factor: 3.598

7.  Comparing surgeon outcomes in endoscopic sinus surgery for chronic rhinosinusitis.

Authors:  Timothy L Smith; Jess C Mace; Luke Rudmik; Rodney J Schlosser; Peter H Hwang; Jeremiah A Alt; Zachary M Soler
Journal:  Laryngoscope       Date:  2016-06-14       Impact factor: 3.325

8.  High Operator and Hospital Volume Are Associated With a Decreased Risk of Death and Stroke After Carotid Revascularization: A Systematic Review and Meta-analysis.

Authors:  Michiel H F Poorthuis; Eelco C Brand; Alison Halliday; Richard Bulbulia; Michiel L Bots; Gert J de Borst
Journal:  Ann Surg       Date:  2019-04       Impact factor: 12.969

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.